Diamond Hill Capital’s AVNS Holdings & Trades

First Buy
Q1 2025
Duration Held
3 Quarters
Largest Add
Q1 2025
+195,364 shares
Current Position
434,661 shares
$5.02 M value

Diamond Hill Capital's AVNS Position Overview

Diamond Hill Capital (via Diamond Hill Capital Management INC) currently holds 434.7K shares of Avanos Medical, Inc. (AVNS) worth $5.02 M, representing 0.02% of the portfolio. First purchased in 2025-Q1, this short-term holding has been held for 3 quarters.

Based on 13F filings, Diamond Hill Capital has maintained this position in AVNS for several quarters, showing initial confidence in the investment. Largest addition occurred in Q2 2025, adding 149.7K shares.

Analysis based on 13F filings available since 2013 Q2

Diamond Hill Capital's Avanos Medical (AVNS) Holding Value Over Time

Track share changes against reported price movement

Quarterly Avanos Medical (AVNS) Trades by Diamond Hill Capital

Period Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q1 2025 +195,364 New Buy 195,364 $14.33
Q2 2025 +149,667 Add 76.61% 345,031 $12.24
Q3 2025 +89,630 Add 25.98% 434,661 $11.56

Diamond Hill Capital's Avanos Medical Investment FAQs

Diamond Hill Capital first purchased Avanos Medical, Inc. (AVNS) in Q1 2025, acquiring 195,364 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Diamond Hill Capital has held Avanos Medical, Inc. (AVNS) for 3 quarters since Q1 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Diamond Hill Capital's largest addition to Avanos Medical, Inc. (AVNS) was in Q1 2025, adding 195,364 shares worth $2.8 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

According to the latest 13F filing for Q3 2025, Diamond Hill Capital's firm, Diamond Hill Capital Management INC, owns 434,661 shares of Avanos Medical, Inc. (AVNS), valued at approximately $5.02 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

As of the Q3 2025 filing, Avanos Medical, Inc. (AVNS) represents approximately 0.02% of Diamond Hill Capital's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Diamond Hill Capital's peak holding in Avanos Medical, Inc. (AVNS) was 434,661 shares, as reported at the end of Q3 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.